elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q27010449-A2058FE2-FF18-4602-9439-7AFC4129DAE3
Q27010449-A2058FE2-FF18-4602-9439-7AFC4129DAE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27010449-A2058FE2-FF18-4602-9439-7AFC4129DAE3
Linaclotide: a new option for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation in adults
P2860
Q27010449-A2058FE2-FF18-4602-9439-7AFC4129DAE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27010449-A2058FE2-FF18-4602-9439-7AFC4129DAE3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cfffa8c8dce1179a84944c8ff05e05d475c16af4
P2860
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation